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Both bacterial and viral pneumonia are well accepted en-
tities; however, with evolving diagnostics there has been
increasing interest in the pathogenesis, epidemiology,
presentation, and prognosis of viral pneumonias. In
addition, the concept of viral and bacterial co-infections
in pneumonia is an area of growing research and may be
best recognized among patients with influenza who de-
velop secondary bacterial infections; there was particular
interest in this after the 2009 pandemic [1–4]. However,
in the setting of increasing molecular diagnostics, par-
ticularly multiplex PCR platforms, there is an opportun-
ity to better define the epidemiology of co-infections
and their impact on clinical diagnosis and patient out-
comes [5, 6]. There is some evidence that dual infection
may worsen patient outcome, including severity of dis-
ease and mortality [1, 2]. With this in mind, the article
by Voiriot et al. [7], “Viral–bacterial coinfection affects
the presentation and alters the prognosis of severe
community-acquired pneumonia”, adds to our expand-
ing knowledge base in this arena.
Prior studies have focused on community-acquired
pneumonia (CAP) with multiplex pathogen panels, and
rates of positivity for concurrent viral detection have
ranged up to approximately half of patients; however,
detecting a virus does not necessarily imply the virus is
directly affecting the patient’s current clinical illness
[1, 3, 4, 8]. The study by Voiriot et al. is a single center,
retrospective study of critically ill patients admitted to
an ICU between October 2011 and June 2015 for
community-acquired pneumonia who also had a
multiplex retrograde pathogen panel completed within
72 h of admission to the ICU. Patients were catego-
rized based on pathogen, including bacterial, viral,
mixed viral and bacterial pathogens, and no etiology
based on microbiologic data obtained. The primary
endpoint was to identify specific features regarding
presentation and prognosis of mixed viral bacterial co-
infected patients. Clinical course was evaluated via a
composite criterion of “complicated course” including
hospital death or utilization of mechanical ventilation
for greater than 7 days. The study included 174 pa-
tients that were predominantly male and of old age.
Patients with microbiologic documentation of infection
included 144 patients: 52.3% had at least one bacter-
ium identified and 56.3% had at least one virus identi-
fied. Of these, 45 had a mixed bacterial and viral
pneumonia per the investigators’ criteria; 15 were in-
fluenza and 14 were picornavirdae. In the analyses, the
composite “complicated course” achieved statistical
significance, with higher rates in the mixed group. Pre-
sentations were also altered, with increased ground-
glass opacities radiographically and increased severity
of illness among those with mixed infection. It is of
note, however, that radiographic findings for bacterial
and viral pneumonia may have significant overlap and
have historically not been particularly predictive of sin-
gle entity, dual, or mixed infection [1].
This retrospective study has several potential limita-
tions (e.g., selection bias, confounding by indication of
ordering or not the multiplex PCR panel) but the results,
limited as they may be, demonstrate that over half of pa-
tients admitted to an ICU with presumed community-
acquired pneumonia have detectable virus at the time of
presentation, consistent with other studies noted above.
In the study by Voiriot et al., dual infection with mixed
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bacterial and viral pathogens was associated with wors-
ening patient outcomes. Interpretation of the study is
somewhat limited as it is difficult to ascertain the clinical
relevance of the detection of virus given the underlying
knowledge that viral shedding is not uncommon. Viral
shedding could be a surrogate marker for disease sever-
ity associated with the primary bacterial pneumonia.
However, the worsened composite outcome would sug-
gest that, regardless of colonization, shedding, or active
infection, the presence of concurrent virus may hold
prognostic value. From a clinician standpoint this be-
comes increasingly of concern as we detect episodes of
mixed infection as very few of the viruses detected on
multiplex platforms have active treatment options. Fur-
ther, it can be difficult in particular patients, such as
those with underlying pulmonary disease, to ascertain
what may be bacterial colonization or shedding versus
active viral infection [6, 8]. The study by Voiriot et al.
did not include discussion of prior infections, particu-
larly in patients with an existing immunocompromised
state that may have predisposed them to persistent viral
shedding, which can last for months.
With all of this in mind, the study by Voiriot et al. re-
inforces prior literature that CAP may be far more com-
plex than has been historically recognized, with potential
dual active infections, possible immune-modulating ef-
fects of some viruses, interactions of the pulmonary
microbiome, and variations in clinical presentation and
prognosis that may be secondary to direct pathogen ef-
fect versus host immune response, or the combination
of all of the above [1, 8]. Further prospective studies are
needed to better determine the role of these viruses and
their interactions in patients with CAP. Unfortunately,
at this time the knowledge of dual infection does not
guarantee changes in clinical practice that would impact
individual patient outcomes given the lack of proven
causal effects from viral–bacterial co-infections, as well
as the paucity of effective antiviral therapy available. De-
tecting a single virus as the pathogen would ideally
equate to improved antimicrobial stewardship, but the
legitimate concern for dual infection may preclude this
[5]. However, it is of great importance that recognition
of active viral replication may portend clinical value
from the infection prevention standpoint as appropriate
isolation may prevent nosocomial spread of viral ill-
nesses, particularly given the high rate of virus detection
[5, 9]. Finally, preventative strategies with vaccination
for both bacterial and viral pathogens remain of para-
mount importance.
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